Protalix BioTherapeuticsPLX 
$1.73-1.70%24h
-1.70%24h
Global rank18595
Market cap$126.21M
Change 7d-1.70%
YTD Performance-2.81%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Protalix BioTherapeutics (PLX)
As of December 2024, Protalix BioTherapeutics has a market cap of $126.21M. This makes Protalix BioTherapeutics the world's 18595th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Protalix BioTherapeutics from 1998 to 2024
-
Value:-
Market cap history of Protalix BioTherapeutics from 1998 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $110.52M | -14.89% |
| 2023 | $129.85M | 29.93% |
| 2022 | $99.94M | 65.06% |
| 2021 | $60.55M | -77.13% |
| 2020 | $264.82M | 10.67% |
| 2019 | $239.28M | 5.81% |
| 2018 | $226.15M | -53.03% |
| 2017 | $481.48M | 46.67% |
| 2016 | $328.28M | -55.88% |
| 2015 | $744.11M | -44.57% |
| 2014 | $1.34B | -52.70% |
| 2013 | $2.84B | -25.05% |
| 2012 | $3.79B | 5.27% |
| 2011 | $3.60B | -50.60% |
| 2010 | $7.28B | 50.76% |
| 2009 | $4.83B | 259.78% |
| 2008 | $1.34B | -45.88% |
| 2007 | $2.48B | -79.64% |
| 2006 | $12.18B | -60.71% |
| 2005 | $31.00B | 2025.00% |
| 2004 | $1.46B | -50.00% |
| 2003 | $2.92B | 263.64% |
| 2002 | $802.47M | -52.17% |
| 2001 | $1.68B | 22.67% |
| 2000 | $1.37B | -78.57% |
| 1999 | $6.38B | -61.11% |
| 1998 | $16.41B | - |
PLX Market Cap Today is $126.21M -1.70% - 24 Dec 2024
View largest stocks by market cap 
